⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

GILD

Gilead Sciences, Inc.

Healthcare · Drug Manufacturers - General

156.04USD

-1.1500 (-0.73%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on GILD.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 156.04
P/E—
Dvd Ind Yld2.1%
P/B16.36
P/S6.4
Curr EV/T12M EBITDA14.7
Mkt Cap (USD)193.5B
Curr EV (USD)214.8B
2)

Per Share Data

EPS T12M-2.67
DPS3.27
Bk Val Per Sh9.53
Rev/Sh24.50
Cash/Sh3.94
Curr Shares Out1,240.0M
FCF/Sh10.41
3)

Cash Flow Analysis

P/CF14.3
Curr P/FCF14.9
CF/NI-4.2
Dvd P/O-125.6%
Cash Gen/Cash Reqd2.9
Csh Dvd Cov3.3
CFO/Sales44.5%
Eff Interest Rate3.9%
4)

Growth Potential

Dil EPS 1Y Gr1684.2%
Cap 1Y Gr3.5%
BPS 1Y Gr17.4%
R&D To Sales30.0%
Retention Rate225.6%
Rev 1Y Gr2.4%
FCF 1Y Gr-8.2%
Assets 1Y Gr0.0%
5)

Profitability

EBITDA-2.1B
EBIT-2.5B
Operating Margin-8.2%
Pretax Margin-6.4%
Net Margin-10.6%
ROA-6.2%
ROE-20.6%
ROC—
Asset Turnover0.58
6)

Structure

Current Ratio1.27
Quick Ratio0.90
Debt/Assets53.2%
Debt/Com Eq221.9%
Net Debt/EBITDA-10.85
Tot Debt/Capital68.9%
Gross Margin79.6%
EBIT/Int Exp-2.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.